Patents by Inventor William J. Houlihan

William J. Houlihan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4451448
    Abstract: Minor tranquilizers preparable by known processes are represented by the following structural formula I: ##STR1## wherein R.sup.o is hydrogen, halo of atomic weight of from 18 to 80, i.e. fluoro, chloro or bromo or alkyl of 1 to 3 carbon atoms,R is halo of atomic weight of from 18 to 80, alkyl of 1 to 4 carbon atoms or trifluoromethyl,R' is alkenyl of 3 to 6 carbon atoms, alkynyl of 3 to 6 carbon atoms, cycloalkyl of 3 to 8 carbon atoms, norbornyl, alkyl of 1 to 3 carbon atoms substituted by cycloalkyl of 3 to 7 carbon atoms or --CH.sub.2 (F.sub.x ALK) wherein x is 1 to 3 and ALK is alkyl of 1 to 4 carbon atoms,R.sub.1, R.sub.2, and R.sub.3 are independently hydrogen or alkyl of 1 or 2 carbon atoms, andn is 0 or 1.
    Type: Grant
    Filed: September 29, 1982
    Date of Patent: May 29, 1984
    Assignee: Sandoz, Inc.
    Inventors: Goetz E. Hardtmann, William J. Houlihan
  • Patent number: 4301170
    Abstract: This disclosure describes novel compounds of the formula ##STR1## wherein R.sub.1 and R.sub.2 each represent hydrogen, or ##STR2## and R.sub.3 is hydrogen or fluoro, andn is 1, 2 or 3, andprovided that one of R.sub.1 and R.sub.2 is other than hydrogen which are useful as anti-obesity agents.
    Type: Grant
    Filed: August 1, 1980
    Date of Patent: November 17, 1981
    Assignee: Sandoz, Inc.
    Inventor: William J. Houlihan
  • Patent number: 4287196
    Abstract: Certain known pyrimido[2,1-a]isoindoles and diazepino[2,1-a]isoindoles, e.g., 7-(p-chlorophenyl)-7-hydroxy-2,3,4,5-tetrahydro-7H-[1,3]-diazepino[2,1-a]i soindoles, are useful for inhibiting prolactin secretion.
    Type: Grant
    Filed: February 26, 1980
    Date of Patent: September 1, 1981
    Assignee: Sandoz, Inc.
    Inventors: Ronald G. Babington, F. Eugene Harrington, William J. Houlihan
  • Patent number: 4228166
    Abstract: Ketone derivatives of 4,5-dihydro-3(2H)-pyridazinones of the formula ##STR1## where R.sub.1 is halo having an atomic weight of from 19 to 36, andR.sub.2 is a branched chain lower alkyl having 3 to 4 carbon atomsare useful as central nervous system depressants, in particular, as muscle relaxants.
    Type: Grant
    Filed: March 5, 1979
    Date of Patent: October 14, 1980
    Assignee: Sandoz, Inc.
    Inventor: William J. Houlihan
  • Patent number: 4219560
    Abstract: This disclosure describes novel compounds of the formula: ##STR1## where A is --CH.sub.2 OH or ##STR2## wherein R.sub.4 and R.sub.5 each independently represent hydrogen or lower alkyl having 1 to 2 carbon atoms or together with N represent ##STR3## and, R.sub.1 is hydrogen or lower alkyl having 1 to 2 carbon atoms, andR.sub.2 and R.sub.3 each independently represent hydrogen, chloro, fluoro, methyl, methoxy or together, represent methylenedioxy, andn is 1 or 2, provided that one of R.sub.2 and R.sub.3 is other than hydrogen which are useful as hypolipidemic agents.
    Type: Grant
    Filed: April 17, 1978
    Date of Patent: August 26, 1980
    Assignee: Sandoz, Inc.
    Inventor: William J. Houlihan
  • Patent number: 4212876
    Abstract: Certain substituted or unsubstituted 2-phenylbenzimidazoles, e.g., 1-methyl-2-phenylbenzimidazole, are useful as anti-obesity agents.
    Type: Grant
    Filed: June 21, 1978
    Date of Patent: July 15, 1980
    Assignee: Sandoz, Inc.
    Inventor: William J. Houlihan
  • Patent number: 4210585
    Abstract: Dibenz[c,f]imidazo[1,2-a][1]azepin-9-ols of the general formula ##STR1## where R.sub.1 represents H or mono or di-chloro or fluoro, andR.sub.2 represents H, chloro, fluoro, alkyl of 1-3 carbon atoms, e.g., methyl, ethyl or isopropyl, alkoxy of 1-3 carbon atoms, e.g., methoxy or ethoxy, or trifluoromethyl,prepared by borohydride hydrogenation of the corresponding 9-ones are useful as anti-convulsant agents.
    Type: Grant
    Filed: June 18, 1979
    Date of Patent: July 1, 1980
    Assignee: Sandoz, Inc.
    Inventor: William J. Houlihan
  • Patent number: 4180671
    Abstract: Dibenz[c,f]imidazo [1,2-a] [1]azepin-9-ols of the general formula ##STR1## where R.sub.1 represents H or mono or di-chloro or fluoro, andR.sub.2 represents H, chloro, fluoro, alkyl of 1-3 carbon atoms, e.g., methyl, ethyl or isopropyl, alkoxy of 1-3 carbon atoms, e.g., methoxy or ethoxy, or trifluoromethyl,prepared by borohydride hydrogenation of the corresponding 9-ones are useful as anti-convulsant agents.
    Type: Grant
    Filed: May 22, 1978
    Date of Patent: December 25, 1979
    Assignee: Sandoz, Inc.
    Inventor: William J. Houlihan
  • Patent number: 4175191
    Abstract: 3-Substituted-4-aryl isoquinolines, e.g. 3-tertiary butyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline, prepared from corresponding isoquinoline intermediates, are useful as anti-diabetic agents.
    Type: Grant
    Filed: November 17, 1977
    Date of Patent: November 20, 1979
    Assignee: Sandoz, Inc.
    Inventors: William J. Houlihan, Jeffrey Nadelson
  • Patent number: 4162317
    Abstract: Succinic acid esters of -4,5-dihydro-3(2H)-pyridazinones of the formula ##STR1## where R.sub.1 is hydrogen or halo having an atomic weight of from 19 to 36, andR.sub.2 is hydrogen, chloro or lower alkyl having 1 to 4 carbon atomsAre useful as central nervous system depressants, in particular, as muscle relaxants.
    Type: Grant
    Filed: May 25, 1978
    Date of Patent: July 24, 1979
    Assignee: Sandoz, Inc.
    Inventor: William J. Houlihan
  • Patent number: 4140859
    Abstract: Imidazo[2,1-a]isoquinolines useful as anorexics and antidepressants are prepared from a dilithium derivative of a 2-(o-tolyl)-2-imidazoline.
    Type: Grant
    Filed: April 13, 1978
    Date of Patent: February 20, 1979
    Assignee: Sandoz, Inc.
    Inventor: William J. Houlihan
  • Patent number: 4136184
    Abstract: Hydroxyalkyl and aryl or heterocyclic substituted-4,5-dihydropyridazin(2H)-3-ones and diazabicyclo-ene-ones e.g., 6-(p-chlorophenyl)-2-(2-hydroxybutyl)-4,5-dihydropyridazin(2H)-3-one are prepared by condensing 1-hydrazino-2-alkanols with aryl or heterocyclic-.gamma.-keto acids and are useful as central nervous system depressants.
    Type: Grant
    Filed: July 22, 1977
    Date of Patent: January 23, 1979
    Assignee: Sandoz, Inc.
    Inventor: William J. Houlihan
  • Patent number: 4107311
    Abstract: Substituted spiro[isoindoline-1,3'(4'H)-isoquinoline]-1',3-diones, e.g., 2,2'-dimethyl spiro[isoindoline-1,3'(4'H)-isoquinoline]-1',3-dione, are prepared by cyclizing .alpha.-(1-hydroxy-3-oxoisoindolin-1-yl)-o-toluamides and are useful as non-estrogenic anti-fertility agents.
    Type: Grant
    Filed: July 7, 1976
    Date of Patent: August 15, 1978
    Assignee: Sandoz, Inc.
    Inventors: William J. Houlihan, Jeffrey Nadelson
  • Patent number: 4101553
    Abstract: Imidazo[2,1-a]isoquinolines useful as anorexics and antidepressants are prepared from a dilithium derivative of a 2-(o-tolyl)-2-imidazoline.
    Type: Grant
    Filed: November 4, 1974
    Date of Patent: July 18, 1978
    Assignee: Sandoz, Inc.
    Inventor: William J. Houlihan
  • Patent number: 4100165
    Abstract: Imidazo[2,1-a]isoquinolines useful as anorexics and anti-depressants, e.g. 5-(2-thienyl)-2,3,5,6-tetrahydroimidazo[2,1-a]isoquinolin-5-ol, are prepared from a dilithium derivative of a 2-(o-tolyl)-2-imidazoline.
    Type: Grant
    Filed: July 22, 1976
    Date of Patent: July 11, 1978
    Assignee: Sandoz, Inc.
    Inventor: William J. Houlihan
  • Patent number: 4083997
    Abstract: 10-(2-substituted-aminoethyl)-10,11-dihydro-5-methylene-2 or 3 7 or 8-substituted or unsubstituted-5H-dibenzo[a,d]cycloheptenes e.g., 10-(2-dimethylaminoethyl)-10,11-dihydro-5-methylene-5H-dibenzo[a,d]cyclohe ptene, prepared by various methods including acid dehydration of the corresponding dibenzo[a,d]cycloheptene-5-ols. The compounds are useful as anti-depressants.
    Type: Grant
    Filed: September 1, 1976
    Date of Patent: April 11, 1978
    Assignee: Sandoz, Inc.
    Inventors: William J. Houlihan, Jeffrey Nadelson
  • Patent number: 4083871
    Abstract: 2-Sec.-alkylaminobenzophenones are prepared by reacting a corresponding 2-aminobenzophenone with a ketone, a borohydride and carboxylic acid.
    Type: Grant
    Filed: January 29, 1976
    Date of Patent: April 11, 1978
    Assignee: Sandoz, Inc.
    Inventors: William J. Houlihan, Paul G. Mattner, Joseph A. Smith
  • Patent number: 4055644
    Abstract: Hydroxyalkyl and aryl or heterocyclic substituted-4,5-dihydropyridazin(2H)-3-ones and diazobicyclo-ene-ones, e.g., 6-(p-chlorophenyl)-2-(2-hydroxybutyl)-4,5-dihydropyridazin(2H)-3-one are prepared by condensing 1-hydrazino-2-alkanols with aryl or heterocyclic-.gamma.-keto acids and are useful as central nervous system depressants.
    Type: Grant
    Filed: September 18, 1975
    Date of Patent: October 25, 1977
    Assignee: Sandoz, Inc.
    Inventor: William J. Houlihan
  • Patent number: 4036855
    Abstract: Imidazo isoindoles, e.g. 5-(p-chlorophenyl)-5-hydroxy-2,3-dihydro-5H-imidazo[2,1a]isoindol, may be prepared by treating a corresponding 2-benzoyl benzoic acid with a substituted ethylene diamine, and treating a resulting intermediate first with concentrated acid and then with base. The products are active as anorexic agents.
    Type: Grant
    Filed: October 29, 1975
    Date of Patent: July 19, 1977
    Assignee: Sandoz, Inc.
    Inventor: William J. Houlihan
  • Patent number: 4036978
    Abstract: Substituted and unsubstituted ethanodibenzoindoles, for example, 3-chloro-1-methyl-1,2-dihydro-6,10b-ethanodibenzo[cd,g] indole, are prepared by cyclizing and reducing N-naphthylbenzamides and are useful as anti-inflammatory agents.
    Type: Grant
    Filed: May 6, 1976
    Date of Patent: July 19, 1977
    Assignee: Sandoz, Inc.
    Inventor: William J. Houlihan